Advertisement

Insurance genetics moratorium extended to 2017

The ABI and government have agreed that the long-standing concordat and moratorium on genetics has been extended to 2017. The next review will take place in 2014.

The concordat and moratorium on the use of predictive genetic test results means people can insure themselves and their families, even if they have had an adverse result from a predictive genetic test. The moratorium has proved effective since its introduction in 2001 and has now been extended to 2017. The moratorium means the results of a predictive genetic test does not affect a consumer’s ability to take out any type of insurance other than life insurance over £500,000. Above this amount, insurers can only use adverse predictive genetic test results for the sole approved test for Huntington’s Disease.

 

Comment on this page »

Features

Latest news

Bupa announce £2.9 million investment

Bupa Cromwell Hospital wins 3 awards

Health-on-Line cycle to raise money for local charity

Insurance genetics moratorium extended to 2017
Advertisement
Advertisement
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information